Cidtuzumab
|
WikiDoc Resources for Cidtuzumab |
|
Articles |
|---|
|
Most recent articles on Cidtuzumab |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Cidtuzumab at Clinical Trials.gov Clinical Trials on Cidtuzumab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Cidtuzumab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Cidtuzumab Discussion groups on Cidtuzumab Patient Handouts on Cidtuzumab Directions to Hospitals Treating Cidtuzumab Risk calculators and risk factors for Cidtuzumab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Cidtuzumab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Cidtuzumab is a humanized monoclonal antibody which is used to treat cancers of the epithelial origin. It binds to interleukin-2.